MYLAN INSTITUTIONAL FDA Approval NDA 020630

NDA 020630

MYLAN INSTITUTIONAL

FDA Drug Application

Application #020630

Documents

Label2004-04-05
Letter2004-03-10
Letter2016-12-20
Label2016-12-21
Label2018-07-04
Review2019-02-15
Letter2019-10-09
Label2019-10-15

Application Sponsors

NDA 020630MYLAN INSTITUTIONAL

Marketing Status

Prescription001
Prescription002
Prescription003

Application Products

001INJECTABLE;INJECTIONEQ 1MG BASE/VIAL1ULTIVAREMIFENTANIL HYDROCHLORIDE
002INJECTABLE;INJECTIONEQ 2MG BASE/VIAL1ULTIVAREMIFENTANIL HYDROCHLORIDE
003INJECTABLE;INJECTIONEQ 5MG BASE/VIAL1ULTIVAREMIFENTANIL HYDROCHLORIDE

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP1996-07-12STANDARD
EFFICACY; EfficacySUPPL2AP1999-11-23STANDARD
LABELING; LabelingSUPPL3AP1999-06-23STANDARD
EFFICACY; EfficacySUPPL5AP2004-03-08STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL6AP2000-09-19STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL7AP2001-11-19STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL8AP2002-12-20STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL9AP2002-10-03STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL14AP2013-06-11STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL15AP2016-01-12STANDARD
LABELING; LabelingSUPPL16AP2016-12-16STANDARD
LABELING; LabelingSUPPL18AP2018-06-21STANDARD
LABELING; LabelingSUPPL20AP2019-10-07STANDARD

Submissions Property Types

SUPPL5Null6
SUPPL6Null0
SUPPL7Null0
SUPPL8Null0
SUPPL9Null0
SUPPL14Null0
SUPPL15Null0
SUPPL16Null15
SUPPL18Null15
SUPPL20Null6

TE Codes

001PrescriptionAP
002PrescriptionAP
003PrescriptionAP

CDER Filings

MYLAN INSTITUTIONAL
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 20630
            [companyName] => MYLAN INSTITUTIONAL
            [docInserts] => ["",""]
            [products] => [{"drugName":"ULTIVA","activeIngredients":"REMIFENTANIL HYDROCHLORIDE","strength":"EQ 1MG BASE\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"ULTIVA","activeIngredients":"REMIFENTANIL HYDROCHLORIDE","strength":"EQ 2MG BASE\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"ULTIVA","activeIngredients":"REMIFENTANIL HYDROCHLORIDE","strength":"EQ 5MG BASE\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"Yes"}]
            [labels] => [{"actionDate":"10\/07\/2019","submission":"SUPPL-20","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/020630s020lbl.pdf\"}]","notes":""},{"actionDate":"06\/21\/2018","submission":"SUPPL-18","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/020630s018lbl.pdf\"}]","notes":""},{"actionDate":"06\/21\/2018","submission":"SUPPL-18","supplementCategories":"Labeling-Container\/Carton Labels","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/020630s018lbl.pdf\"}]","notes":""},{"actionDate":"12\/16\/2016","submission":"SUPPL-16","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/020630s016lbl.pdf\"}]","notes":""},{"actionDate":"12\/16\/2016","submission":"SUPPL-16","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/020630s016lbl.pdf\"}]","notes":""},{"actionDate":"03\/08\/2004","submission":"SUPPL-5","supplementCategories":"Efficacy-New Patient Population","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2004\\\/20630se5-005_ultiva_lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"ULTIVA","submission":"REMIFENTANIL HYDROCHLORIDE","actionType":"EQ 1MG BASE\/VIAL","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"ULTIVA","submission":"REMIFENTANIL HYDROCHLORIDE","actionType":"EQ 2MG BASE\/VIAL","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"ULTIVA","submission":"REMIFENTANIL HYDROCHLORIDE","actionType":"EQ 5MG BASE\/VIAL","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2019-10-07
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.